The National Kidney Foundation of Michigan (NKFM) works to shape public policy on behalf of kidney disease patients and those at risk, those with diabetes and high blood pressure, the leading causes of kidney failure. It is our goal to assess and support proposed state and federal policies that will help us to move toward a healthier Michigan and prevent chronic kidney disease when possible.
The National Kidney Foundation of Michigan's main focus is maintaining the state funding for programs to prevent or manage diabetes high blood pressure and kidney disease. These programs are critical to improving quality of life for those living with kidney disease and those at risk. We work to maintain this funding and educate lawmakers about its importance.
As advocates for the National Kidney Foundation of Michigan, we also keep track of policies related to access to medications, medical treatment for diabetes and kidney patients, policies that promote healthy and safe communities, and policies that increase organ donation in Michigan.
The National Kidney Foundation of Michigan's national office, NKF, offers a number of volunteer advocacy opportunities on their website. Click here to view all that they offer: https://www.kidney.org/advocacy
Resources for Advocacy
Click here to download the 2019-2020 Legislative Handout. This document is a two-part tool to help educate and inform state legislators about obesity, diabetes, and kidney disease in Michigan. It both informs about the challenge of these three epidemics and calls legislators to take action to promote solutions for a healthier Michigan. This document also highlights the successes of state-funded programs for preventing obesity, diabetes and kidney disease.
Michigan Legislature: legislature.mi.gov
Michigan House of Representatives: house.michigan.gov
Michigan Senate: senate.michigan.gov
Visit votesmart.org to learn who represents you in Congress (federal government in Washington D.C.) or in the Michigan Legislature (state government in Lansing).
Thank you, Senator Gary Peters!
Thank you to Senator Gary Peters for supporting living organ donors and kidney patients by becoming a co-sponsor of the Living Donor Protection Act (S.511/H.R.1224). No American should risk insurance discrimination or job loss from the selfless act of living organ donation. We so thankful to see that Senator Peters agrees. We hope he will continue to champion fairness for living organ donors and kidney disease patients by encouraging his colleagues in Congress to join you as a cosponsor of this urgently needed legislation.
Thank you for your continued support to the 30 million Americans affected by kidney disease and the more than one million in Michigan. With more than 2,200 people waiting just for a life-saving kidney transplant in Michigan, your efforts will help improve organ donations for all. The NKFM would also like to thank Erich Ditschman for his continued and passionate dedication to this cause and for his many years of support!
For more information on the Living Donor Protection Act and what you can do to help, visit NKF Advocacy.
CKD Issues & Legislation
The National Kidney Foundation (NKF) helps to shape public policy on behalf of kidney disease patients. We work with Congress and federal agencies, as well as with state governments to further legislation and regulation that improve the care and quality of life of kidney disease patients.
Chronic Kidney Disease - NKF is calling on Congress to expand the Chronic Kidney Disease Control Program at the Centers for Disease Control and Prevention to support early detection and treatment among high-risk populations.
Dialysis — The Health Care Reform movement in Congress provides an opportunity to expand the choices available to dialysis patients.
Transplantation and Organ Donation — To help close the gap that exists between the need for organs for transplantation and organ availability, NKF advocates for ways to increase the supply of organs for transplantation and to help recipients keep the transplant they have received.
Health Care Reform — Significant changes to health care access, financing, and the delivery of care will occur with the enactment of health reform legislation in March 2010. The new law will impact private insurance as well as Medicare and Medicaid.
Extending Medicare Coverage of Immunosuppressive Drugs
Every year, thousands of kidney patients receive a Medicare covered transplant. Medicare benefits, including coverage of immunosuppressive drugs, continue without a time limit for aged or disabled beneficiaries. Kidney recipients who are non-aged or non-disabled retain Medicare eligibility only for 36 months following their transplants. Many ESRD beneficiaries face the challenge of enrolling in private health insurance or otherwise paying for their immunosuppressive medications when coverage ends. Extending Medicare immunosuppressive coverage would improve outcomes and enable more kidney patients to consider transplantation. The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 - H.R. 1428, introduced by Representatives Michael Burgess (R-TX) and Ron Kind (D-WI) and S. 323, introduced by Senator Durbin (D-IL) and Senator Cochran (R-MS) - will help kidney transplant recipients obtain the life-saving immunosuppressive medications that are necessary to maintain the viability of their new kidney.
Maintain funding for the Centers for Disease Control and Preventions Chronic Kidney Disease Program
The Chronic Kidney Disease (CKD) Program at the Centers for Disease Control and Prevention (CDC) helps reduce the burden of CKD through early detection and treatment programs aimed at high-risk populations. Since 2006, Congress has provided direct funding for a CKD program within CDC's Division of Diabetes Translation at approximately $2 million per year. CDC initiated an agreement with NKF to test a community-based screening program to identify people at high risk (individuals with diabetes, hypertension, or over age 50). More than 900 people in four states (California, Florida, Minnesota, and New York) were screened, and the evaluation of this data is under final review. These results will help assess the effectiveness of early detection and intervention. To enable CDC to continue to identify people at high risk of CKD and track its progression, NKF is working with Members of the Appropriations Committee to request that Congress to maintain funding at $2.2 million for FY 2014.
For more information on national advocacy and legislation, visit the National Kidney Foundation at www.kidney.org.
Thank you for your continued support of the NKFM and our mission to prevent kidney disease and improve quality of life for those living with it.